Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam Oral Solution Dosing for Sedation During Pediatric Dental GA Induction
ChiCTR2500111405Phase 4Recruiting
- Sponsor
- School of Stomatology, Fourth Military Medical University
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of midazolam in carious lesion (3 arms), sponsored by School of Stomatology, Fourth Military Medical University. Primary endpoint: Optimal dose of midazolam oral solution for reducing induction anxiety. Started Oct 2025; status: recruiting.
02
Drugs
midazolam
03
Conditions
carious lesion
Beyond the preview
Go deeper on ChiCTR2500111405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500111405.